Innovent Biologics, Inc. (HKG: 1801)
Hong Kong
· Delayed Price · Currency is HKD
33.05
+0.05 (0.15%)
Jan 28, 2025, 12:08 PM HKT
Innovent Biologics Employees
Innovent Biologics had 4,872 employees as of December 31, 2023. The number of employees decreased by 422 or -7.97% compared to the previous year.
Employees
4,872
Change (1Y)
-422
Growth (1Y)
-7.97%
Revenue / Employee
1.52M HKD
Profits / Employee
-261.61K HKD
Market Cap
54.14B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
BeiGene | 10,600 |
Hansoh Pharmaceutical Group Company | 9,123 |
JD Health International | 3,118 |
WuXi Biologics | 12,740 |
Sinopharm Group | 115,959 |
Alibaba Health Information Technology | 1,435 |
Akeso | 2,778 |
CSPC Pharmaceutical Group | 23,500 |
Innovent Biologics News
- 15 days ago - Innovent Biologics Inc (IVBIY) Announces NMPA Approval of Limertinib for Lung Cancer Treatment - GuruFocus
- 15 days ago - Innovent Biologics Inc (IVBIY) Unveils Strategic Growth Plans at J.P. Morgan Healthcare Conference - GuruFocus
- 15 days ago - Innovent and ASK Pharm Jointly Announce NMPA Approval of Limertinib, a Third-generation EGFR TKI for the Treatment of Lung Cancer - PRNewsWire
- 15 days ago - Innovent Presents at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 16 days ago - Innovent Biologics Inc (IVBIY) Secures Breakthrough Therapy Designation for IBI343 in Advanced ... - GuruFocus
- 16 days ago - Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer - PRNewsWire
- 26 days ago - Innovent Biologics Inc (IVBIY) to Present at 43rd Annual J.P. Morgan Healthcare Conference - GuruFocus
- 26 days ago - Innovent to Participate and Present at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire